Condition
Non Small Cell Lung Carcinoma
Estimated Enrollment: 228
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: H3E-BL-O027-PS2|H3E – US -I023|INCA-Lung001
Study First Received: December 30, 2010
Last Updated: April 18, 2013
Estimated Primary Completion Date: January 2012
Primary Outcome Measures:
Overall survival|Safety evaluation|Progression free survival|Response Rate
Sponsors and Collaborators:
Instituto Nacional de Cancer, Brazil|Eli Lilly and Company
Website Link: https://ClinicalTrials.gov/show/NCT01836575
